Filter Results:
(2,142)
Show Results For
- All HBS Web
(2,142)
- People (2)
- News (469)
- Research (1,566)
- Events (1)
- Multimedia (13)
- Faculty Publications (1,187)
Show Results For
- All HBS Web
(2,142)
- People (2)
- News (469)
- Research (1,566)
- Events (1)
- Multimedia (13)
- Faculty Publications (1,187)
- 16 Dec 2014
- First Look
First Look: December 16
oppose the standards, relative to external users (credit analysts and the broader citizenry), but the difference is moderated in states with constitutionally protected benefits. This finding is consistent with the expectation that pension accounting View Details
Keywords: Sean Silverthorne
- 22 Jun 2009
- Research & Ideas
“Too Big To Fail”: Reining In Large Financial Firms
leverage and reforming the credit rating system. The Case Against A Systemic Risk Regulator In a lengthy minority dissent, the oversight panel's two Republicans, Texas Congressman Jeb Hensarling and former New Hampshire Senator John... View Details
- 01 Sep 2010
- News
RX for Change
don’t assume a one-to-one translation of everything we teach,” he adds. “There are differences, and we’re respectful of those differences.” Related Links Case Study: One Hospital’s Approach to Health-Care Reform HBS faculty on U.S.... View Details
- 01 Jun 2010
- News
M.I.A. Boards
been addressed, investors return to the markets, and the cycle continues. In light of this poor regulatory track record, we believe government-mandated reforms and more regulation alone cannot solve the current crisis of corporate... View Details
- March 2021 (Revised January 2023)
- Case
The Trouble with TCE
By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details
Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States
Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
- January 2018
- Article
The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials
By: Aaron V. Kaplan and Ariel D. Stern
The introduction of new medical devices has transformed cardiovascular care in recent decades. Devices, such as heart valves, pacemakers, stents, ventricular assist devices, and implantable defibrillators, have prolonged and improved the quality of life for millions of... View Details
Keywords: Health Testing and Trials; Business and Government Relations; Governing Rules, Regulations, and Reforms; Information Publishing; Medical Devices and Supplies Industry; United States
Kaplan, Aaron V., and Ariel D. Stern. "The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials." JAMA Cardiology 3, no. 1 (January 2018): 5–6.
- April – May 2010
- Article
Banking Deregulations, Financing Constraints and Firm Entry Size
By: William R. Kerr and Ramana Nanda
We examine the effect of US branch banking deregulations on the entry size of new firms using micro-data from the US Census Bureau. We find that the average entry size for startups did not change following the deregulations. However, among firms that survived at least... View Details
Keywords: Business Startups; Financing and Loans; Governing Rules, Regulations, and Reforms; Market Entry and Exit; Banking Industry; United States
Kerr, William R., and Ramana Nanda. "Banking Deregulations, Financing Constraints and Firm Entry Size." Journal of the European Economic Association 8, nos. 2-3 (April–May 2010): 582–593.
- September 2008 (Revised September 2011)
- Background Note
Note: Credit Rating Agencies
The note examines the role of credit rating agencies in capital markets, with emphasis on the role of these agencies in the recent credit crisis and recommendations for change. View Details
Keywords: Financial Crisis; Capital Markets; Credit; Governing Rules, Regulations, and Reforms; Standards
Fruhan, William E. "Note: Credit Rating Agencies." Harvard Business School Background Note 209-056, September 2008. (Revised September 2011.)
- 14 Dec 2016
- Working Paper Summaries
The State of Small Business Lending: Innovation and Technology and the Implications for Regulation
- Forthcoming
- Article
Antitrust Platform Regulation and Entrepreneurship: Evidence from China
By: Ke Rong, D. Daniel Sokol, Di Zhou and Feng Zhu
Many jurisdictions have launched antitrust enforcement and brought in regulation of large tech platforms. The swift and strict implementation of China’s Anti-Monopoly Guidelines for the Platform Economy (Platform Guidelines) provides a quasi-natural experiment... View Details
Keywords: Platform; Antitrust; Regulation; Entrepreneurship; Venture Capital; Governing Rules, Regulations, and Reforms; Competition; Market Entry and Exit; Supply and Industry; China
Rong, Ke, D. Daniel Sokol, Di Zhou, and Feng Zhu. "Antitrust Platform Regulation and Entrepreneurship: Evidence from China." Management Science (forthcoming).
- February 2025
- Case
Abiomed: A Change of Heart
By: Satish Tadikonda, Faith Robertson and William Marks
After acquiring Impella CardioSystems AG in May 2005, Abiomed Inc., a company focused on cardiac care, ran into a dilemma. Its Impella 2.5 device was approved for use in the European Union, but CEO Michael Minogue had seemingly bet the company's future on the ability... View Details
Keywords: Mergers and Acquisitions; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Business and Government Relations; Medical Devices and Supplies Industry; European Union; United States
Tadikonda, Satish, Faith Robertson, and William Marks. "Abiomed: A Change of Heart." Harvard Business School Case 825-011, February 2025.
- July, 2024
- Article
Consumer Protection in an Online World: An Analysis of Occupational Licensing
By: Chiara Farronato, Andrey Fradkin, Bradley Larsen and Erik Brynjolfsson
We study the demand and supply implications of occupational licensing using transaction-level data from a large online platform for home improvement services. We find that demand is more responsive to a professional's reviews than to the professional's... View Details
Keywords: Occupational Licensing; Consumer Protection; Perception; Experience and Expertise; Public Opinion; Governing Rules, Regulations, and Reforms; Demand and Consumers
Farronato, Chiara, Andrey Fradkin, Bradley Larsen, and Erik Brynjolfsson. "Consumer Protection in an Online World: An Analysis of Occupational Licensing." American Economic Journal: Applied Economics 16, no. 3 (July, 2024): 549–579.
- Article
Does Your Company Need a Chief Medical Officer?
By: Tsedal Neeley
With the Covid-19 pandemic still raging but businesses trying to remain operational, organizations now have a life or death role to play in protecting the health of employees, customers, and the public. That means they need a new executive in the C-suite: a chief... View Details
Keywords: COVID-19 Pandemic; Health; Health Pandemics; Organizational Change and Adaptation; Organizational Structure; Safety; Governing Rules, Regulations, and Reforms; Working Conditions
Neeley, Tsedal. "Does Your Company Need a Chief Medical Officer?" Harvard Business Review (website) (October 1, 2020).
- 2022
- Working Paper
The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives
By: Ariel Dora Stern
For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details
Keywords: AI and Machine Learning; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Technological Innovation; Medical Devices and Supplies Industry
Stern, Ariel Dora. "The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives." NBER Working Paper Series, No. 30639, December 2022.
- December 2019 (Revised September 2020)
- Case
Facebook Faces the Regulators
By: Debora L. Spar
In the fall of 2019, Facebook and its CEO Mark Zuckerberg are facing increased scrutiny on multiple fronts. Regulators from around the globe are threatening the company with punitive measures. Users are organizing against it. But there is little consensus around what,... View Details
Keywords: Facebook; Regulation; Media; Internet and the Web; Governance; Governing Rules, Regulations, and Reforms; Business and Government Relations; Social Media; Europe
Spar, Debora L. "Facebook Faces the Regulators." Harvard Business School Case 720-019, December 2019. (Revised September 2020.)
- April 2012 (Revised July 2012)
- Supplement
Man Group (B)
By: Robert C. Pozen and Thomas M. Clay
The Man Group was a huge and successful UK-based hedge fund and fund of funds manager. Through acquisitions, the company had consciously diversified its portfolio of investment products. In 2007 Man had to decide whether or not to spin off its brokerage business. Man... View Details
Keywords: Hedge Funds; Asset Management; Governing Rules, Regulations, and Reforms; Investment Funds; Corporate Strategy; Growth and Development Strategy; Financial Services Industry; United Kingdom
Pozen, Robert C., and Thomas M. Clay. "Man Group (B)." Harvard Business School Supplement 312-129, April 2012. (Revised July 2012.)
- October 2009 (Revised November 2016)
- Case
Generation Health: A Pioneer in Genetics Benefit Management (A)
By: Robert F. Higgins, Jeffrey D. Marrazzo and Rachel Gordon
Generation Health, a pioneer in the new field of genetics benefit management and a newly formed company, faces many strategic issues. CEO Per Lofberg is in the midst of negotiating a partnership with a major pharmacy benefit management company. As part of these... View Details
Keywords: Business Startups; Entrepreneurship; Governing Rules, Regulations, and Reforms; Growth and Development Strategy; Partners and Partnerships; Genetics; Health Industry; Insurance Industry
Higgins, Robert F., Jeffrey D. Marrazzo, and Rachel Gordon. "Generation Health: A Pioneer in Genetics Benefit Management (A)." Harvard Business School Case 810-007, October 2009. (Revised November 2016.)
- 2005
- Chapter
Environmental Federalism in the European Union and the United States
By: David Vogel, Michael W. Toffel and Diahanna Post
The United States (US) and the European Union (EU) are federal systems in which the responsibility for environmental policy-making is divided or shared between the central government and the (member) states. The attribution of decision-making power has important policy... View Details
Keywords: Governing Rules, Regulations, and Reforms; Policy; Government Legislation; Natural Environment; Pollutants; Climate Change; European Union; United States
Vogel, David, Michael W. Toffel, and Diahanna Post. "Environmental Federalism in the European Union and the United States." Chap. 9 in A Handbook of Globalisation and Environmental Policy: National Government Interventions in a Global Arena, edited by F. Wijen, K. Zoeteman, and J. Pieters, 247–276. Cheltenham, U.K.: Edward Elgar Publishing, 2005.
- 2000
- Other Unpublished Work
New Trading Practices and the Short-run Predictability of the S&P 500: Market Volatility and Investor Confidence, Report to the Board of Directors of the New York Stock Exchange, Inc.
By: André Perold